Back to Evidence
Primary experimental recordPositive observation

PMC12016742::ACT015712

GI

Evidence text

Paper-level observation

a higher number of human CD8+ T cells in the spleen following treatment with StCl‐GI_GII + αPD‐1 compared to StCl‐GI_GII (P = 0.0023) and PBS (P = 0.0001) (Figure 6e).
textConfidence: medium

Assay observation

Activity
Immunomodulatory
Subtype
Antibacterial
Measure
percent_inhibition
Comparator
=
Raw observation
P = 0.0023 vs StCl-GI_GII; P = 0.0001 vs PBS
Normalized measurement
=0.0023
Value minimum
Not reported by source
Value maximum
Not reported by source
Target
Homo sapiens
Assay method
Not reported by source
Sequence
EGSRNQDWL
Standardization
ready simple

Source publication

Off‐The‐Shelf Multivalent Nanoconjugate Cancer Vaccine Rescues Host Immune Response against Melanoma

Advanced Materials · 2025

Related peptide identities

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.